Schedule 13D ownership disclosure
Can-Fite BioPharma Ltd.
Security class unavailable · CUSIP: 13471N201
Event date: 2019-07-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.8800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-19-001863
- Form type
- SC 13D
- Filer
- Can-Fite BioPharma Ltd.
- CIK
- CIK 1536196
- Filed
- Jul 10, 2019
- Reporting period
- Jul 03, 2019
- Description
- Schedule 13D beneficial ownership